Combined effects of cyclooxygenase‐1 and cyclooxygenase‐2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice

Abstract

As with cyclooxygenase (COX)-2, genetic disruption of COX-1 gene or pharmacologic inhibition of its activity has been shown to decrease the number of intestinal polyps in Apc gene-deficient mice. The present study was designed to investigate the combined effects of COX-1 and COX-2 selective inhibitors on spontaneous polyp formation in APC1309 female mice. The animals were treated with 300 or 600 ppm mofezolac (a COX-1 selective inhibitor) alone, 200 or 400 ppm nimesulide (a COX-2 selective inhibitor) alone, 300 ppm mofezolac plus 200 ppm nimesulide, 600 ppm mofezolac plus 400 ppm nimesulide, or 10 ppm indomethacin (a dual-COX inhibitor) in the diet from 7 weeks of age for 4 weeks. Percentage inhibition of polyp area in the intestine was 17% with 600 ppm mofezolac alone and 25% with 400 ppm nimesulide alone, their sum of 42% being almost equal to the 37% observed for the combination treatment. Administration of 300 ppm mofezolac plus 200 ppm nimesulide also significantly decreased polyp area in the intestine by 30%. Moreover, the numbers of polyps more than 2.5 mm in diameter were markedly decreased by combined treatment of both COX inhibitors. With 10 ppm indomethacin, the dual inhibitor, polyp area was also clearly reduced by 46%. Our results indicate that COX-1 and COX-2 may to some extent contribute to polyp formation independently and inhibitor combination treatment thus has particular potential for chemoprevention of colon carcinogenesis. © 2004 Wiley-Liss, Inc. Key words: Apc knockout mice; COX-1 selective inhibitor; COX-2 selective inhibitor; intestinal tumorigenesis; combined effectLong-term use of aspirin, a nonsteroidal antiinflammatory drug (NSAID), has been found in the epidemiologic studies to result in reduction in mortality rate from colorectal cancer. 1,2 Furthermore, treatment with NSAIDs suppresses the development of chemical carcinogen-induced colon cancers in experimental animals. 3,4 Similarly, decrease has been achieved with such agents regarding intestinal polyps in patients with familial adenomatous polyposis (FAP) [5][6][7] and in an animal model of the disease, mutant mice with a truncated adenomatous polyposis coli (Apc) gene. 8 NSAIDs block arachidonic acid metabolism by inhibiting cyclooxygenase (COX) activity and thus reducing levels of prostaglandins, which affect cell proliferation, tumor growth, apoptosis and immune responsiveness. Two enzyme isoforms of COX are known, referred to as COX-1 and COX-2. COX-1 is constitutively expressed in most tissues and plays a role in various physiologic functions, while COX-2 is transiently inducible by stimuli such as cytokines, growth factors and hormones and contributes to inflammation. 9 By using COX-2 selective inhibitors or mutant mice featuring disruption of the gene encoding this enzyme, relevance to carcinogenesis in various organs, including the colon, has been shown. 10 -13 Possible involvement of COX-1 in colon carcinogenesis has also been reported. Genetic disruption of the COX-1 gene decreased the number of intestinal polyps in ...

Effects of cyclooxygenase inhibitors on survival time in ovarian cancer xenograft-bearing mice

“…In the same study (20), we identified that combined coxib therapy produced significant potential synergistic suppressive effects on tumor growth in comparison with the same doses of either SC-560 or celecoxib following 14 days of treatment. This was in accordance with the results from Kitamura et al (21) who revealed that combination therapy with mofezolac (a COX-1 selective inhibitor) and nimesulide (a COX-2 selective inhibitor) has particular potential for chemoprevention of colon carcinogenesis compared with the effects of either coxib as monotherapy.…”

Host knockout of E-prostanoid 2 receptors reduces tumor growth and causes major alterations of gene expression in prostaglandin E2-producing tumors

“…By contrast, Cox-1 and 15-Pgdh were upregulated. COX-1 has similar effects as COX-2 in tumor models (29,30), while 15-PGDH degrades prostaglandins. The transporter of prostaglandins across cell membranes was also downregulated in the tumors from the EP2-knockout mice in the present study.…”

Synthesis of Novel Curcumin Analogues and Their Evaluation as Selective Cyclooxygenase-1 (COX-1) Inhibitors

“…11) Very recently, experimental results have also indicated a possible involvement of the other isoform of COX, COX-1, in angiogenesis, thereby providing the rationale for the development of selective COX-1 inhibitors. 12,13) These data were also confirmed by in vitro studies in isolated ovine COX-1 and COX-2 enzymes which showed that curcumin and its analogues tetrahydrocurcumin and trimethoxydibenzoylmethane had significantly higher inhibitory effects on the peroxidase activity of COX-1 than that of COX-2.…”